Eyecelerator, a partner of the American Academy of Ophthalmology, is self-described as having the goal of advancing eye care ...

Preoperative identification and eradication of Demodex can improve ocular-surface comfort and may mitigate cataract-surgery ...

Oculis Holding AG announced that the final patient visit has been completed in the DIAMOND phase 3 program assessing OCS-01, ...

Propensity-matched analyses showed smokers had significantly higher risk across all studied ocular outcomes over 10 years, ...

Self-reported hearing impairment reduced the likelihood of achieving clinically meaningful functional improvement after ...

Christopher E. Starr, MD, FACS, highlights diagnostic gaps in dry eye, emphasizing neuropathic corneal pain and reviewing ...

Motugivatrep introduces first-in-class topical TRPV1 antagonism for DED, targeting corneal nociceptor-driven discomfort ...

The early results from a phase II study on the use of the topotecan episcleral chemoplaque (Targeted Therapy Technologies LLC ...

New 52-week analyses from the phase 3 SOL-1 trial suggest that the investigational intravitreal therapy AXPAXLI (OTX-TKI) may ...

Uncorrected acuity at 36 months showed continuous range: monocular 20/20 distance and intermediate, 20/27 near; binocular ...

Glaukos Corporation announced that the US Centers for Medicare and Medicaid Services (CMS) has assigned a permanent ...

Gabriel discusses a robotic femtosecond laser platform for LASIK, focusing on flap accuracy, stromal bed precision, and the ...